Literature DB >> 20496475

Severity of liver injury and atherogenic lipid profile in children with nonalcoholic fatty liver disease.

Valerio Nobili1, Naim Alkhouri, Andrea Bartuli, Melania Manco, Rocio Lopez, Anna Alisi, Ariel E Feldstein.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome. The aim of this study was to assess the relationship between severity of liver injury and atherogenic lipid profile in a large group of children with NAFLD. A total of 118 consecutive children with biopsy-proven NAFLD were included. Patients underwent extensive metabolic profiling. The NAFLD activity and fibrosis scores showed a significant positive correlation with triglyceride/HDL, total cholesterol/HDL, and LDL/HDL ratios (p<0.05) but not with apolipoprotein B/apolipoprotein A-1 ratio (p=0.58). After adjusting for BMI, homeostatic model assessment, impaired glucose tolerance, and presence of metabolic syndrome, both the NAFLD activity score and stage of fibrosis remained independent predictors of proatherogenic lipid profile. All lipid ratios, except for apolipoprotein B/apolipoprotein A-1, were found to be markedly higher in children with nonalcoholic steatohepatitis compared with those with simple steatosis or borderline disease (p<0.05). This study shows for the first time that in children with NAFLD, the severity of liver injury is strongly associated with the presence of a more atherogenic lipid profile, having potential significant diagnostic and therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20496475     DOI: 10.1203/PDR.0b013e3181da4798

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  26 in total

1.  Atherogenic dyslipidemia and cardiovascular risk in children with nonalcoholic fatty liver disease.

Authors:  Naim Alkhouri; Christine Carter-Kent; Michael Elias; Ariel E Feldstein
Journal:  Clin Lipidol       Date:  2011-06-01

2.  The relationship between pediatric nonalcoholic fatty liver disease and cardiovascular risk factors and increased risk of atherosclerosis in obese children.

Authors:  Selim Gökçe; Zehra Atbinici; Zehra Aycan; Hasibe Gökçe Cınar; Pelin Zorlu
Journal:  Pediatr Cardiol       Date:  2012-08-09       Impact factor: 1.655

3.  NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN).

Authors:  Miriam B Vos; Stephanie H Abrams; Sarah E Barlow; Sonia Caprio; Stephen R Daniels; Rohit Kohli; Marialena Mouzaki; Pushpa Sathya; Jeffrey B Schwimmer; Shikha S Sundaram; Stavra A Xanthakos
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-02       Impact factor: 2.839

Review 4.  Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk.

Authors:  Lucia Pacifico; Valerio Nobili; Caterina Anania; Paola Verdecchia; Claudio Chiesa
Journal:  World J Gastroenterol       Date:  2011-07-14       Impact factor: 5.742

5.  Reduction of Some Atherogenic Indices in Patients with Non-Alcoholic Fatty Liver by Vitamin D and Calcium Co-Supplementation: A Double Blind Randomized Controlled Clinical Trial.

Authors:  Farzad Shidfar; Seyedeh Neda Mousavi; Hamid Lorvand Amiri; Shahram Agah; Sharieh Hoseini; Seyed Javad Hajimiresmail
Journal:  Iran J Pharm Res       Date:  2019       Impact factor: 1.696

6.  Improvement in liver histology is associated with reduction in dyslipidemia in children with nonalcoholic fatty liver disease.

Authors:  Kathleen E Corey; Raj Vuppalanchi; Miriam Vos; Rohit Kohli; Jean P Molleston; Laura Wilson; Aynur Unalp-Arida; Oscar W Cummings; Joel E Lavine; Naga Chalasani
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-03       Impact factor: 2.839

7.  Nonalcoholic fatty liver disease and the heart in children and adolescents.

Authors:  Lucia Pacifico; Claudio Chiesa; Caterina Anania; Antonio De Merulis; John Frederick Osborn; Sara Romaggioli; Eugenio Gaudio
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

Review 8.  Nonalcoholic fatty liver disease and vascular disease: state-of-the-art.

Authors:  Silvia Fargion; Marianna Porzio; Anna Ludovica Fracanzani
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

Review 9.  Nonalcoholic Fatty Liver Disease in Children: Not a Small Matter.

Authors:  Praveen Kumar Conjeevaram Selvakumar; Mohammad Nasser Kabbany; Naim Alkhouri
Journal:  Paediatr Drugs       Date:  2018-08       Impact factor: 3.022

10.  Dyslipidemia is associated with pediatric nonalcoholic fatty liver disease.

Authors:  Shima Dowla; Stella Aslibekyan; Amy Goss; Kevin Fontaine; Ambika P Ashraf
Journal:  J Clin Lipidol       Date:  2018-04-03       Impact factor: 4.766

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.